Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency

Bone

Volumn 32, Issue 2, 2003, Pages 170-179

  Ahmad, A M ^a   Hopkins, M T ^a   Fraser, W D ^a   Ooi, C G ^a   Durham, B H ^a   Vora, J P ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adult growth hormone deficiency; Circadian rhythm; Nephrogenous cyclic adenosine monophosphate; Parathyroid hormone; Phosphate; Procollagen type I amino terminal propeptide; Type I collagen C telopeptides

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CALCIUM; COLLAGEN TYPE 1; CREATININE; CYCLIC AMP; PARATHYROID HORMONE; PEPTIDE DERIVATIVE; PHOSPHATE; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; UNCLASSIFIED DRUG; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HUMAN; MALE; NEPHRON; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; REGULATORY MECHANISM; UREA BLOOD LEVEL; URINALYSIS; URINARY EXCRETION; URINE LEVEL; VENOUS BLOOD;

EID: 0037291852     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00952-3     Document Type: Article

References (44)

1. Rosén T., Wilhelmsen L., Landin-Wilhelmsen K., Lappas G., Bengtsson B.A. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol. 137:1997;240-245.
2. Boonen S., Lesaffre E., Dequeker J., Aerssens J., Nijs J., Pelemans W., Bouillon R. Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years potential implications for the prevention of age-related bone loss . J Am Geriatr Soc. 44:1996;1301-1306.
3. Lindsay R., Nieves J., Formica C., Henneman E., Woelfert L., Shen V., Dempster D., Cosman F. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet. 350:1997;550-555.
4. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 104:1999;439-446.
5. el-Hajj Fuleihan G., Klerman E.B., Brown E.N., Choe Y., Brown E.M., Czeisler C.A. The parathyroid hormone circadian rhythm is truly endogenous - a general clinical research center study. J Clin Endocrinol Metab. 82:1997;281-286.
6. Fraser W.D., Logue F.C., Christie J.P., Gallacher S.J., Cameron D., O'Reilly D.S., Beastall G.H., Boyle I.T. Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis. Osteoporos Int. 8:1998;121-126.
7. Lobaugh B., Neelon F.A., Oyama H., Buckley N., Smith S., Christy M., Leight G.S. Jr. Circadian rhythms for calcium, inorganic phosphorus, and parathyroid hormone in primary hyperparathyroidism functional and practical considerations . Surgery. 106:1989;1009-1016.
8. Eastell R., Calvo M.S., Burritt M.F., Offord K.P., Russell R.G., Riggs B.L. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab. 74:1992;487-494.
9. Nielsen H.K., Laurberg P., Brixen K., Mosekilde L. Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone, and ionized calcium in normal individuals. Acta Endocrinol. 124:1991;391-398.
10. Kitamura N., Shigeno C., Shiomi K., Lee K., Ohta S., Sone T., Katsushima S., Tadamura E., Kousaka T., Yamamoto I., Dokoh S., Konishi J. Episodic fluctuation in serum intact parathyroid hormone concentration in men. J Clin Endocrinol Metab. 70:1990;252-263.
11. Kripke D., Lavie P., Parker D., Huey L., Deftos L. Plasma parathyroid hormone and calcium are related to sleep cycles. J Clin Endocrinol Metab. 47:1978;1021-1027.
12. Logue F.C., Fraser W.D., O'Reilly D.S., Christie J., Cameron D.A., Wallace D.C., Beastall G.H. Sleep shift dissociates the nocturnal peaks of parathyroid hormone (1-84), nephrogenous cyclic adenosine monophosphate, and prolactin in normal men. J Clin Endocrinol Metab. 75:1992;25-29.
13. Calvo M., Kuman R., Heath H. Persistently elevated parathyroid hormone secretion and action in young women after 4 weeks of ingesting high phosphorus, low calcium diets. J Clin Endocrinol Metab. 70:1990;1334-1340.
14. Estepa J.C., Aguilera Tejero E., Lopez I., Almaden Y., Rodriguez M., Felsenfeld A.J. Effect of phosphate on parathyroid hormone secretion in vivo. J Bone Miner Res. 14:1999;1848-1854.
15. Almaden Y., Hernandez A., Torregrosa V., Canalejo A., Sabate L., Fernandez Cruz L., Campistol J.M., Torres A., Rodriguez M. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol. 9:1998;1845-1852.
16. Karkkainen M., Lamberg-Allardt C. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women. J Bone Miner Res. 11:1996;1905-1912.
17. Kilav R., Silver J., Naveh-Many T. Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest. 96:1995;327-333.
18. Lancer S.R., Bowser E.N., Hargis G.K., Williams G.A. The effect of growth hormone on parathyroid function in rats. Endocrinology. 98:1975;1289-1293.
19. Hock J.M., Fonseca J. Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone. Endocrinology. 127:1990;1804-1810.
20. Burstein S., Chen I.W., Tsang R.C. Effects of growth hormone replacement therapy on 1,25-dihydroxyvitamin D and calcium metabolism. J Clin Endocrinol Metab. 56:1983;1246-1251.
21. Bengtsson B.A., Edén S., Lönn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tölli J., Sjöström L., Isaksson O.G. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:1993;309-317.
22. Holmes S.J., Mawer E.B., Shalet S.M. Effect of growth hormone replacement on calcium, phosphate, vitamin D and parathyroid hormone metabolism in adults with growth hormone deficiency. Endocrinol Metab. 4:1997;49-54.
23. Marcus R., Butterfield G., Holloway L., Gilliland L., Baylink D.J., Hintz R.L., Sherman B.M. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab. 70:1990;519-527.
24. Hayden J.M., Mohan S., Baylink D.J. The insulinlike growth factor system and the coupling of formation to resorption. Bone. 17:1995;93S-98S.
25. Dempster D.W., Cosman F., Parisien M., Shen V., Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr Rev. 14:1993;690-709.
26. Rouleau M.F., Mitchell J., Goltzman D. In vivo distribution of parathyroid hormone receptors in bone evidence that a predominant osseous target cell is not the mature osteoblast . Endocrinology. 123:1988;187-191.
27. Sartorio A., Conti A., Monzani M., Morabito F., Faglia G. Growth hormone treatment in adults with GH deficiency effects on new biochemical markers of bone and collagen turnover . J Endocrinol Invest. 16:1993;893-898.
28. Gardner M.D., Dryburgh F.J., Fyffe J.A., Jenkins A.S. Predictive value of derived calcium figures based on the measurement of ionised calcium. Ann Clin Biochem. 18:1981;106-109.
29. O'Reilly D.S., Fraser W.D., Penney M.D., Logue F.C., Cowan R.A., Williams B.C., Walters G. Arginine infusion blocks the action of parathyroid hormone but not arginine vasopressin on the renal tubule in man. J Endocrinol. 111:1986;501-506.
30. Broadus A.E., Mahaffey J.E., Bartter F.C., Neer R.M. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest. 60:1977;771-783.
31. Mojon A., Fernandez J.R., Hermida R.C. Chronolab an interactive software package for chronobilogic time series analysis written for the Macintosh computer . Chronobiol Int. 9:1992;403-412.
32. Bingham C., Arbogast B., Guillaume G.C., Lee J.K., Halberg F. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia. 9:1982;397-439.
33. Markowitz M.E., Arnaud S., Rosen J.F., Thorpy M., Laximinarayan S. Temporal interrelationships between the circadian rhythms of serum parathyroid hormone and calcium concentrations. J Clin Endocrinol Metab. 67:1988;1068-1073.
34. Ledger G.A., Burritt M.F., Kao P.C., O'Fallon W.M., Riggs B.L., Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab. 80:1995;3304-3310.
35. Gertner J.M., Horst R.L., Broadus A.E., Rasmussen H., Genel M. Parathyroid function and vitamin D metabolism during human growth hormone replacement. J Clin Endocrinol Metab. 49:1979;185-188.
36. Ogle G.D., Rosenberg A.R., Kainer G. Renal effects of growth hormone. II. Electrolyte homeostasis and body composition. Paediatr Nephrol. 6:1992;483-489.
37. Inzucchi S.E., Robbins R.J. Effects of growth hormone on human bone biology. J Clin Endocrinol Metab. 79:1994;691-694.
38. Broadus A.E. Mineral balance and homeostasis. Favus M. Primer on the metabolic bone diseases and disorders of mineral metabolism. 1999;74-80 Lippincott Williams & Wilkins, Philadelphia.
39. Mallete L.E., Kirkland J.L. Fine regulation of serum calcium acute midday decreases in calcium ion concentration trigger a parathyroid response . Cohn D.V., Fujita T., Potts J.T.J. Endocrine control of bone and calcium metabolism. 1984;71-88 Elsevier, New York.
40. Moodley G.P., Pettifor J.M., Sefuba M. Comparison of two commercial ionised calcium analysers, and values in South African blacks. S Afr Med J. 72:1987;193-196.
41. White T.F., Farndon J.R., Conceicao S.C., Laker M.F., Ward M.K., Kerr D.N. Serum calcium status in health and disease a comparison of measured and derived parameters . Clin Chim Acta. 157:1986;199-213.
42. Eastell R., Delmas P.D., Hodgson S.F., Eriksen E.P., Mann K.G. Bone formation rate in older normal women concurrent assessment with bone histomorphometry, calcium kinetics and biochemical markers . J Clin Endocrinol Metab. 67:1988;741-748.
43. Riggs B.L., Melton L.J. Clinical heterogeneity of involutional osteoporosis implications for preventive therapy . J Clin Endocrinol Metab. 70:1990;1229-1232.
44. Eastell R., Simmons P.S., Colwell A., Assiri A.M., Burritt M.F., Russell R.G., Riggs B.L. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentrations and urinary deoxypyridinoline excretion-effects of growth and aging. Clin Sci. 83:1992;375-382.